Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

FLOWOOD PAIN CENTER, LLC

NPI: 1356848014 · FLOWOOD, MS 39232 · Interventional Pain Medicine Physician · NPI assigned 04/10/2018

$1.26M
Total Medicaid Paid
45,954
Total Claims
40,970
Beneficiaries
31
Codes Billed
2018-04
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGREEN, TERESA (REVENUE MANAGER)
NPI Enumeration Date04/10/2018

Related Entities

Other providers sharing the same authorized official: GREEN, TERESA

ProviderCityStateTotal Paid
CITY OF TACOMA TACOMA WA $79.79M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,106 $15K
2019 2,445 $25K
2020 6,355 $140K
2021 8,593 $295K
2022 11,141 $299K
2023 6,644 $239K
2024 8,670 $245K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 21,019 19,121 $748K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5,436 4,897 $169K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5,709 5,281 $107K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,521 1,326 $86K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 725 657 $37K
62323 493 456 $29K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 144 133 $17K
64493 296 194 $16K
64483 91 77 $9K
64494 470 195 $7K
99442 329 277 $6K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,356 1,065 $6K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 2,153 2,046 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 123 93 $3K
99441 444 359 $3K
64495 87 56 $2K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 43 34 $2K
J1040 Injection, methylprednisolone acetate, 80 mg 398 362 $1K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 28 27 $1K
62321 38 25 $726.33
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 86 76 $636.05
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,793 1,537 $504.67
99406 104 84 $494.91
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 1,584 1,390 $345.63
J1885 Injection, ketorolac tromethamine, per 15 mg 971 800 $212.17
64484 14 14 $97.98
20610 12 12 $24.31
J2704 Injection, propofol, 10 mg 374 272 $21.73
J1030 Injection, methylprednisolone acetate, 40 mg 18 17 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 80 75 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 15 12 $0.00